FXN and cerebellar ataxia: In several ataxia treatment studies, frataxin itself has emerged as a key drug target.[44] Combining cryogenic and room‐temperature structures CyaY—the bacterial homolog of frataxin—enhances our drug‐design efforts by revealing dynamic side‐chain rotamers, and key water‐mediated interactions that cryo alone may miss.